Improved clinical status in fibromyalgia patients treated with individualized homeopathic remedies versus placebo

I. R. Bell, II A. Lewis, A. J. Brooks, Gary E Schwartz, S. E. Lewis, B. T. Walsh, C. M. Baldwin

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Objective. To assess the efficacy of individualized classical homeopathy in the treatment of fibromyalgia. Methods. This study was a double-blind, randomized, parallel-group, placebo-controlled trial of homeopathy. Community-recruited persons (N = 62) with physician-confirmed fibromyalgia (mean age 49 yr, S.D. 10 yr, 94% women) were treated in a homeopathic private practice setting. Participants were randomized to receive oral daily liquid LM (1/50 000) potencies with an individually chosen homeopathic remedy or an indistinguishable placebo. Homeopathic visits involved joint interviews and concurrence on remedy selection by two experienced homeopaths, at baseline, 2 months and 4 months (prior to a subsequent optional crossover phase of the study which is reported elsewhere). Tender point count and tender point pain on examination by a medical assessor uninvolved in providing care, self-rating scales on fibromyalgia-related quality of life, pain, mood and global health at baseline and 3 months, were the primary clinical outcome measures for this report. Results. Fifty-three people completed the treatment protocol. Participants on active treatment showed significantly greater improvements in tender point count and tender point pain, quality of life, global health and a trend toward less depression compared with those on placebo. Conclusions. This study replicates and extends a previous 1-month placebo-controlled crossover study in fibromyalgia that pre-screened for only one homeopathic remedy. Using a broad selection of remedies and the flexible LM dose (1/50 000 dilution factor) series, the present study demonstrated that individualized homeopathy is significantly better than placebo in lessening tender point pain and improving the quality of life and global health of persons with fibromyalgia.

Original languageEnglish (US)
Pages (from-to)577-582
Number of pages6
JournalRheumatology
Volume43
Issue number5
DOIs
StatePublished - May 2004

Fingerprint

Materia Medica
Fibromyalgia
Homeopathy
Placebos
Pain
Quality of Life
Cross-Over Studies
Private Practice
Self Care
Clinical Protocols
Joints
Outcome Assessment (Health Care)
Interviews
Depression
Physicians
Therapeutics
Global Health

Keywords

  • Chronic pain
  • Fibromyalgia
  • Global health
  • Homeopathy

ASJC Scopus subject areas

  • Neuroscience(all)
  • Rheumatology

Cite this

Improved clinical status in fibromyalgia patients treated with individualized homeopathic remedies versus placebo. / Bell, I. R.; Lewis, II A.; Brooks, A. J.; Schwartz, Gary E; Lewis, S. E.; Walsh, B. T.; Baldwin, C. M.

In: Rheumatology, Vol. 43, No. 5, 05.2004, p. 577-582.

Research output: Contribution to journalArticle

Bell, I. R. ; Lewis, II A. ; Brooks, A. J. ; Schwartz, Gary E ; Lewis, S. E. ; Walsh, B. T. ; Baldwin, C. M. / Improved clinical status in fibromyalgia patients treated with individualized homeopathic remedies versus placebo. In: Rheumatology. 2004 ; Vol. 43, No. 5. pp. 577-582.
@article{e6b6d827c42d4b6ea05b9c7e77bf2c66,
title = "Improved clinical status in fibromyalgia patients treated with individualized homeopathic remedies versus placebo",
abstract = "Objective. To assess the efficacy of individualized classical homeopathy in the treatment of fibromyalgia. Methods. This study was a double-blind, randomized, parallel-group, placebo-controlled trial of homeopathy. Community-recruited persons (N = 62) with physician-confirmed fibromyalgia (mean age 49 yr, S.D. 10 yr, 94{\%} women) were treated in a homeopathic private practice setting. Participants were randomized to receive oral daily liquid LM (1/50 000) potencies with an individually chosen homeopathic remedy or an indistinguishable placebo. Homeopathic visits involved joint interviews and concurrence on remedy selection by two experienced homeopaths, at baseline, 2 months and 4 months (prior to a subsequent optional crossover phase of the study which is reported elsewhere). Tender point count and tender point pain on examination by a medical assessor uninvolved in providing care, self-rating scales on fibromyalgia-related quality of life, pain, mood and global health at baseline and 3 months, were the primary clinical outcome measures for this report. Results. Fifty-three people completed the treatment protocol. Participants on active treatment showed significantly greater improvements in tender point count and tender point pain, quality of life, global health and a trend toward less depression compared with those on placebo. Conclusions. This study replicates and extends a previous 1-month placebo-controlled crossover study in fibromyalgia that pre-screened for only one homeopathic remedy. Using a broad selection of remedies and the flexible LM dose (1/50 000 dilution factor) series, the present study demonstrated that individualized homeopathy is significantly better than placebo in lessening tender point pain and improving the quality of life and global health of persons with fibromyalgia.",
keywords = "Chronic pain, Fibromyalgia, Global health, Homeopathy",
author = "Bell, {I. R.} and Lewis, {II A.} and Brooks, {A. J.} and Schwartz, {Gary E} and Lewis, {S. E.} and Walsh, {B. T.} and Baldwin, {C. M.}",
year = "2004",
month = "5",
doi = "10.1093/rheumatology/keh111",
language = "English (US)",
volume = "43",
pages = "577--582",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Improved clinical status in fibromyalgia patients treated with individualized homeopathic remedies versus placebo

AU - Bell, I. R.

AU - Lewis, II A.

AU - Brooks, A. J.

AU - Schwartz, Gary E

AU - Lewis, S. E.

AU - Walsh, B. T.

AU - Baldwin, C. M.

PY - 2004/5

Y1 - 2004/5

N2 - Objective. To assess the efficacy of individualized classical homeopathy in the treatment of fibromyalgia. Methods. This study was a double-blind, randomized, parallel-group, placebo-controlled trial of homeopathy. Community-recruited persons (N = 62) with physician-confirmed fibromyalgia (mean age 49 yr, S.D. 10 yr, 94% women) were treated in a homeopathic private practice setting. Participants were randomized to receive oral daily liquid LM (1/50 000) potencies with an individually chosen homeopathic remedy or an indistinguishable placebo. Homeopathic visits involved joint interviews and concurrence on remedy selection by two experienced homeopaths, at baseline, 2 months and 4 months (prior to a subsequent optional crossover phase of the study which is reported elsewhere). Tender point count and tender point pain on examination by a medical assessor uninvolved in providing care, self-rating scales on fibromyalgia-related quality of life, pain, mood and global health at baseline and 3 months, were the primary clinical outcome measures for this report. Results. Fifty-three people completed the treatment protocol. Participants on active treatment showed significantly greater improvements in tender point count and tender point pain, quality of life, global health and a trend toward less depression compared with those on placebo. Conclusions. This study replicates and extends a previous 1-month placebo-controlled crossover study in fibromyalgia that pre-screened for only one homeopathic remedy. Using a broad selection of remedies and the flexible LM dose (1/50 000 dilution factor) series, the present study demonstrated that individualized homeopathy is significantly better than placebo in lessening tender point pain and improving the quality of life and global health of persons with fibromyalgia.

AB - Objective. To assess the efficacy of individualized classical homeopathy in the treatment of fibromyalgia. Methods. This study was a double-blind, randomized, parallel-group, placebo-controlled trial of homeopathy. Community-recruited persons (N = 62) with physician-confirmed fibromyalgia (mean age 49 yr, S.D. 10 yr, 94% women) were treated in a homeopathic private practice setting. Participants were randomized to receive oral daily liquid LM (1/50 000) potencies with an individually chosen homeopathic remedy or an indistinguishable placebo. Homeopathic visits involved joint interviews and concurrence on remedy selection by two experienced homeopaths, at baseline, 2 months and 4 months (prior to a subsequent optional crossover phase of the study which is reported elsewhere). Tender point count and tender point pain on examination by a medical assessor uninvolved in providing care, self-rating scales on fibromyalgia-related quality of life, pain, mood and global health at baseline and 3 months, were the primary clinical outcome measures for this report. Results. Fifty-three people completed the treatment protocol. Participants on active treatment showed significantly greater improvements in tender point count and tender point pain, quality of life, global health and a trend toward less depression compared with those on placebo. Conclusions. This study replicates and extends a previous 1-month placebo-controlled crossover study in fibromyalgia that pre-screened for only one homeopathic remedy. Using a broad selection of remedies and the flexible LM dose (1/50 000 dilution factor) series, the present study demonstrated that individualized homeopathy is significantly better than placebo in lessening tender point pain and improving the quality of life and global health of persons with fibromyalgia.

KW - Chronic pain

KW - Fibromyalgia

KW - Global health

KW - Homeopathy

UR - http://www.scopus.com/inward/record.url?scp=1442293760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1442293760&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/keh111

DO - 10.1093/rheumatology/keh111

M3 - Article

VL - 43

SP - 577

EP - 582

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 5

ER -